Eli Lilly and Co’s COVID-19 antibody drug gets emergency approval
New York: Drug regulators in the US have given emergency use approval for Eli Lilly and Co's investigational monoclonal antibody ...
Read moreDetails
New York: Drug regulators in the US have given emergency use approval for Eli Lilly and Co's investigational monoclonal antibody ...
Read moreDetailsIndianapolis (US): Pharma firm Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not ...
Read moreDetailsWashington: Drug company, Eli Lilly said it has asked the US government to allow emergency use of an experimental antibody ...
Read moreDetailsWashington: Drug company ‘Eli Lilly’ has said that partial results from a study testing an antibody drug give hints that ...
Read moreDetails
The effects of US President Donald Trump’s imposition of a 50 per cent tariff on Indian goods have started to...
Read moreDetails
Companies have long justified sustainability initiatives as a way to boost their reputation, comply with external and internal standards, or...
Read moreDetails
Almost two years into the war in Gaza, the Israeli security cabinet has approved yet another military escalation — a...
Read moreDetails
In February 2018 the Trump White House drew up the ‘US strategic framework for the Indo-Pacific’. This paper, declassified in...
Read moreDetails
